We are a leading, bio-innovative company developing stem cell-based gene therapy for
>the treatment of neurological disorders for which no alternative pharmacological treatments are currently available.
To address critical areas of unmet medical needs, we have created a pipeline of
stem cell-based gene therapy candidates that use mesenchymal stem cells as cell mediators to deliver therapeutic genes.